SLC2A1 and ductal breast carcinoma in situ: The clinicopathological characteristics and expression of ER, PR, HER2, HIF-1α, CAIX and Glut-1 of BRCA1, BRCA2 and non-BRCA mutation-related DCIS cases are described in Table 1.